List of posters
Posters should be displayed all the time during the conference. Presenting authors should be at posters during poster sessions on Thursday, March 25, 20:30 - 22:00 (posters 1 - 23) and Friday, March 26, 20:30 - 22:00 (posters 24 - 56).
List of posters:
P1. Q. An: Influence of oxygen on biological function in CD133-expressing glioma cells
P2. Petra Avanzo: Cnispin, trypsin-specific inhibitor from the basidiomycete
Clitocybe nebularis
P3. Mojca Bizjak: Protective nutrition and cancer
P4. Vladimir B. Bregar: Agglomeration of nanoparticles for drug delivery in
different physiological solutions
P5. Anja Bubik: Cyclic cyanopeptides and cell signaling in tumour cell lines invitro
P6. Maruška Budič: Cloning and expression of Phaseolus vulgaris L. drought-
responsive protease genes
P7. Miha Butinar: The role of cysteine cathepsins inhibitor in tumourprogression and metastasis
P8. Roberta Castino: The oncosuppressor and autophagy modulator PTENregulates multidrug resistance in ovarian cancer
P9. Petra Cerkovnik: Class C CpG ODNs in combination with tumourirradiation creates a unique in situ tumour vaccine
P10. Sophie Chabot: LNA-based oligos delivery by electropulsation
P11. Chiara Compagnin: PEGylated liposomes for the delivery of hydrophobicphotosensitizers
P12. Jasmina Živa Černe: Hormone replacement therapy use and other generallyrecognized breast cancer risk factors among Slovenian postmenopausalwomen
P13. Tanja Dolinšek: Effect of siRNA molecules targeting endoglin on endoglinexpression level and cell viability in a human microvascular endothelial cellline in vitro
P14. Patrick F. Forde: Combined immunogene therapy and regulatory T-cellsinactivation in treatment of weakly immunogenic solid tumours
P15. Kivanc Gorgulu: Analysis of tobacco mosaic virus(TMV) on primary(Colo-320) and metastatic (Colo-741) human colon cancer cells treatedwith α-lactalbumin or sulindac
P16. Saša Haberl: Visualization of DNA-cell interaction during gene
electrotransfer for different Mg!+ ion concentrations
P17. Anja Hafner: The role of γ1-syntrophin in regulating γ-enolase-mediatedneurotrophic effect
P18. Julija Hmeljak: Survivin expression in malignant pleural mesothelioma
P19. Rosana Hudej: The bioassay media for electroporation in vitro
P20. Vid Janša: Number of microvesicles in patients with gastrointestinalstromal tumours treated by imatinib
P21. Jure Jelenc: Sonoporation of mouse melanoma cells B16-F1 withmicrobubbles
P22. Saša Kenig: Endothelial cells increase invasiveness of glioblastoma cells viaSDF-1, cathepsin B and MMP9
P23. Tatyana A. Khalikova: Lysosomal cathepsins B, L, and D in murineexperimental leukemias
P24. Slavko Kralj: Binding of monoclonal antibodies onto the silica-coated
fluorescent magnetic nanoparticles
P25. Petra Kramarič: Electrochemotherapy as a single and adjuvant treatmentof cutaneous tumours in horses
P26. Simona Kranjc: The effect of antioxidants on electrotransfection efficiencyin the C2C12 cell line in vitro and in mouse muscle tibialis cranialis in vivo
P27. Zaynah Maherally: Hyaluronic acid (CD44) and polio virus (CD155)receptors: expression and role in glioma invasion
P28. Barbara Mali: Influence of electrochemotherapy of internal tumours onelectrocardiogram
P29. Boštjan Markelc : The effect of electroporation on normal blood vesselpermeability in mice
P30. Cécil J. W. Meulenberg: Electrochemotherapy of cultured humanmicrovascular endothelial cells in vitro
P31. Francesca Moret: In vitro cellular responses elicited by PEGylatedORMOSIL nanoparticles
P32. Gabriela Panter: Cancer immunotherapy by constitutively active Toll-likereceptor 4
P33. Urša Pečar Fonović: Cathepsin S shedds transmembrane chemokinefractalkine: a brain microglia/neuronal cells co-culture model
P34. Jana Petković: TiO! nanoparticle induced DNA damage and alterations inexpression of DNA damage responsive genes in human hepatoma HepG2cells
P35. Marko Pezdirc: Genotoxicity and bioactivation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in HepG2 cells
P36. Jure Pohleven: Inhibitory action of a lectin from mushroom Clitocybenebularis on human leukemic T cells
P37. Sara Prijič: Increased internalization of superparamagnetic nanoparticlesinto malignant cells by an external magnetic field
P38. Monika Primon: The change of protease expression profile during hMCSspontaneous transformation has an influence on TMC’s characteristics
P39. Anja Pucer: Differential expression of the full set of human secretoryphospholipases A2 in breast cancer cell lines
P40. Gorazd Pucihar: Experimental investigation of electroporation pulseequivalent parameters
P41. Matija Rojnik: Targeted PLGA and PEG-PLGA nanoparticles forimproving photodynamic therapy in cancer
P42. Aleš Sedlar: Radiosensitizing effect of intratumoural mIL-12 electrogenetherapy on murine sarcoma
P43. Mojca Stražišar: Gene expression profiling of non-small cell lung cancer
P44. Petra Sušanj: The temperature effect on number of microvesicles fromperipheral blood
P45. Alja Štraser: The cianobacterial hepatotoxin nodularin induces DNAdamage and reactive oxygen species formation in HepG2 cells
P46. Tine Thursion: A new assay for the measurement of the liberated domain Iof the urokinase receptor in plasma improves the prediction of survival incolorectal cancer
P47. Ana Torkar: Design and synthesis of selective cathepsin L activity basedprobes (ABP)
P48. Mireille Treeby: The role of endocytosis in uptake of nucleic acid moleculesafter electrotransfection of cells
P49. Nina Trošt: Recombinant human erythropoietin (rHuEPO): Mechanismof transcription activation in breast cancer cell lines
P50. Metka Volavšek: Significant up-regulation of NPC1 in colorectal and lungadenocarcinoma
P51. Abigail Frances Welford: Preventing TIE!+ macrophage infiltration incombination with vascular-disrupting agents may enhance the treatmentof solid tumours
P52. Irena Zajc: Xanthohumol induces differential cytotoxicity and triggersapoptotic pathways in normal astrocytes and in glioblastoma cells
P53. Svetlana Zhanaeva: Relationship between the sensitivity to theinduction of apoptosis in mice lymphosarcoma cells and cysteine proteaseactivity in tumour tissue
P54. Daša Zupančič: Uroplakin expression and apical plasma membranestructure in low grade papillary urothelial tumours induced by N-butyl-N-(4-hidroxybutyl)nitrosamine in rats
P55. Valerija Žager: Development of cell-based biosensor systems for detectionof genetic damage
P56. Anže Županič: Method of treatment planning for electrochemotherapy ofdeep-seated tumour lesions
P57. Urška Tajnšek: Systems biology approach for cellular therapy of pancreatic cancer

